Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus.

Abstract:

:Neonatal lupus erythematosus (NLE) is an uncommon condition usually associated with maternal anti-Ro autoantibodies. The cutaneous lesions of NLE are usually transient, disappearing about six months after birth, but telangiectasia is a rare complication of NLE which persists. Telangiectasias are small focal red macules and papules created by abnormally prominent capillaries, venules, and arterioles and are a characteristic marker of connective tissue diseases. We report the case of an infant diagnosed with NLE presenting typical annular lesions, positive ANA and positive anti-Ro antibodies. By five months of age, both ANA and anti-Ro antibodies were negative and the annular cutaneous lesions had gradually faded, but small scattered focal red macules appeared on the face, especially in the peri-orbital area and scalp. The cutaneous lupus disappeared but the telangiectasia persisted. We would like to suggest that the diagnosis of NLE should be considered when cutaneous telangiectasias are observed in infants.

journal_name

Lupus

journal_title

Lupus

authors

Guinovart RM,Vicente A,Rovira C,Suñol M,González-Enseñat MA

doi

10.1177/0961203311430701

subject

Has Abstract

pub_date

2012-04-01 00:00:00

pages

552-5

issue

5

eissn

0961-2033

issn

1477-0962

pii

0961203311430701

journal_volume

21

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Why not work on T and NK cells in the Kunkel laboratory?

    abstract::Coming from Hans Wigzell's laboratory in Uppsala, Sweden, I joined the Kunkel laboratory in 1981 to spend a post-doctoral fellowship period financed by the German Research Organization. While I initially worked with Nick Chiorazzi in an attempt to generate monoclonal antibody-secreting human B-cell hybridomas, I later...

    journal_title:Lupus

    pub_type: 传,历史文章,杂志文章

    doi:10.1191/0961203303lu355xx

    authors: Kabelitz D

    更新日期:2003-01-01 00:00:00

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice.

    abstract::The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB x NZWF1 (B/WF1) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease bega...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu483oa

    authors: Hasegawa K,Hayashi T

    更新日期:2003-01-01 00:00:00

  • Superior mesenteric artery syndrome and intra-abdominal compartment syndrome in systemic lupus erythematosus.

    abstract::Gastrointestinal manifestations of systemic lupus erythematosus (SLE) are common, occurring in about 50% of cases. They are usually mild, in the form of mouth ulcers, nausea, heartburn and mild abdominal pain, but they can be severe in cases of gastrointestinal vasculitis. In this report we describe an unusual combina...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313517150

    authors: Bedaiwi M,Alkubeyyer MA,Al Arfaj AS

    更新日期:2014-02-01 00:00:00

  • Pregnancies in women with systemic lupus erythematosus and antiphospholipid antibodies.

    abstract::Systemic lupus erythematosus (SLE) has preponderance in women in their childbearing years; consequently pregnancy has always been an important issue of concern for the patient and the treating physician. Based upon numerous reports on successful pregnancy outcomes in the past decades, the initial advice against pregna...

    journal_title:Lupus

    pub_type: 评论,杂志文章

    doi:10.1177/0961203315627201

    authors: Schreiber K

    更新日期:2016-04-01 00:00:00

  • Risk-attitude and patient treatment preferences.

    abstract::Women's treatment preferences for lupus nephritis vary widely even after adjusting for sociodemographic factors and disease severity. Attitude toward risk may partially explain interpatient variability in treatment preference. The objective of this study was to examine the association between 'risk-attitude' and patie...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu371oa

    authors: Fraenkel L,Bogardus ST Jr,Wittink DR

    更新日期:2003-01-01 00:00:00

  • Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.

    abstract::HIN200 is a human IFN-inducible gene and homologous to murine IFI202 gene, which was identified as a candidate gene for SLE susceptibility in lupus mouse model. We determined these gene expressions in leukocytes from 20 SLE patients and 10 healthy controls and in renal biopsies from 29 SLE patients and 15 kidney donor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106699

    authors: Kimkong I,Avihingsanon Y,Hirankarn N

    更新日期:2009-10-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.

    abstract::We conducted an open-labeled, prospective study to determine the efficacy and safety of tacrolimus as an alternative therapeutic option for those patients with refractory lupus nephritis. The study population comprised one male and eight female patients with diffuse proliferative lupus nephritis. All patients had fail...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1177/0961203310366573

    authors: Lee T,Oh KH,Joo KW,Kim YS,Ahn C,Han JS,Kim S,Chin HJ

    更新日期:2010-07-01 00:00:00

  • Infodemiology of systemic lupus erythematous using Google Trends.

    abstract::Objective People affected by chronic rheumatic conditions, such as systemic lupus erythematosus (SLE), frequently rely on the Internet and search engines to look for terms related to their disease and its possible causes, symptoms and treatments. 'Infodemiology' and 'infoveillance' are two recent terms created to desc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317691372

    authors: Radin M,Sciascia S

    更新日期:2017-07-01 00:00:00

  • Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age.

    abstract::Objective The main aim of this study was to investigate the ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age. Methods We enrolled 40 SLE patients of childbearing age and 40 age-matched healthy controls. Anti-Müllerian hormone (AMH) was teste...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317726378

    authors: Gao H,Ma J,Wang X,Lv T,Liu J,Ren Y,Li Y,Zhang Y

    更新日期:2018-03-01 00:00:00

  • Induced abortions in women with systemic lupus erythematosus.

    abstract:OBJECTIVES:To determine the rates of induced abortions in women with systemic lupus erythematosus (SLE) compared to women from the general population and assess disease-related predictors of induced abortion in women with SLE. METHODS:We identified women with SLE (15-45 years) and determined the number of induced abor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320979741

    authors: Venne K,Scott S,Bernatsky S,Vinet E

    更新日期:2020-12-15 00:00:00

  • The CD11b-integrin (ITGAM) and systemic lupus erythematosus.

    abstract::Variations at the ITGAM gene, which encodes for the CD11b chain of the Mac-1 (alphaMbeta2; CD11b/CD18; complement receptor-3) integrin, is one of the strongest genetic risk factors for systemic lupus erythematosus (SLE). More specifically, a genetic variant (rs1143679) which results in an arginine to histidine substit...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313491851

    authors: Fagerholm SC,MacPherson M,James MJ,Sevier-Guy C,Lau CS

    更新日期:2013-06-01 00:00:00

  • Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

    abstract::We examined the prevalence of clinical and immunologic features of systemic lupus erythematosus (SLE) by race, sex and age in a population-based study of 265 SLE patients. Patients fulfilled the American College of Rheumatology classification criteria. The median time between diagnosis and study enrollment was 13 mont...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1191/0961203302lu161oa

    authors: Cooper GS,Parks CG,Treadwell EL,St Clair EW,Gilkeson GS,Cohen PL,Roubey RA,Dooley MA

    更新日期:2002-01-01 00:00:00

  • Prevalence and incidence of systemic lupus erythematosus in the adult population of Estonia.

    abstract::Studies have demonstrated considerable variability in systemic lupus erythematosus (SLE) incidence and prevalence estimates. Lack of reliable epidemiological data may hinder evidence-based health care planning. The aim of the present study was to estimate the prevalence and incidence of SLE in the Estonian adult popul...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316686705

    authors: Otsa K,Talli S,Harding P,Parsik E,Esko M,Teepere A,Tammaru M

    更新日期:2017-09-01 00:00:00

  • Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial.

    abstract:OBJECTIVE:Studies have been conducted to determine the causal factors and clinical consequences of non-adherence to treatment in systemic lupus erythematosus (SLE). However, no interventions have been performed to increase drug adherence. Our objective was to assess the effectiveness of pharmaceutical care (PC) for dru...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203319877237

    authors: Oliveira-Santos M,Verani JFS,Camacho LAB,de Andrade CAF,Klumb EM

    更新日期:2019-10-01 00:00:00

  • Bone marrow analysis of immune cells and apoptosis in patients with systemic lupus erythematosus.

    abstract:OBJECTIVES:To examine the immune cell profile in the bone marrow of systemic lupus erythematosus (SLE) patients and to assess its clinical relevance. METHODS:Sixteen bone marrow samples from 14 SLE patients were compared with seven healthy control samples. The numbers of immune cells and apoptotic cells in the bone ma...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314531634

    authors: Park JW,Moon SY,Lee JH,Park JK,Lee DS,Jung KC,Song YW,Lee EB

    更新日期:2014-09-01 00:00:00

  • Pathogenesis of the antiphospholipid antibody syndrome.

    abstract::Endothelial and/or platelet activation likely initiates thrombus formation. Whether antiphospholipid antibody (aPL) is an activator, a toxic response, or a protective response is not clear, nor is it certain whether aPL is germ-line encoded or antigen-driven. The pregnancy model is particularly informative. Alternativ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500514

    authors: Lockshin MD

    更新日期:1996-10-01 00:00:00

  • Incidence and risk analysis of aortic aneurysm and aortic dissection among patients with systemic lupus erythematosus: a nationwide population-based study in Taiwan.

    abstract:OBJECTIVE:The objective of our study was to determine the incidence rates and risk factors of aortic aneurysm and aortic dissection among patients with systemic lupus erythematosus (SLE) using a nationwide population-based data set. METHODS:We conducted a retrospective cohort study using data from the Taiwan National ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314523868

    authors: Wang SH,Chang YS,Liu CJ,Lai CC,Chen TJ,Chen WS

    更新日期:2014-06-01 00:00:00

  • Autoimmunity, infertility and assisted reproductive technologies.

    abstract::Despite strongly held opinions, a trustworthy scientific basis for most statements about autoimmunity, autoimmune diseases and assisted reproductive technologies (ART) does not exist. It is not likely that autoimmunity causes infertility, nor that patients with autoimmune diseases are unusually infertile. When careful...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu2000oa

    authors: Lockshin MD

    更新日期:2004-01-01 00:00:00

  • Advanced MRI techniques: biomarkers in neuropsychiatric lupus.

    abstract::Objectives The objective of this study was to determine whether advanced MRI could provide biomarkers for diagnosis and prognosis in neuropsychiatric systemic lupus erythematosus (NPSLE). Methods Our prospective study included 28 systemic lupus erythematosus (SLE) patients with primary central NPSLE, 22 patients witho...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316674820

    authors: Sarbu N,Toledano P,Calvo A,Roura E,Sarbu MI,Espinosa G,Lladó X,Cervera R,Bargalló N

    更新日期:2017-04-01 00:00:00

  • Cyclophosphamide for lupus during pregnancy.

    abstract::Severe systemic lupus erythematosus often requires the use of cyclophosphamide in women of reproductive age. As cyclophosphamide is generally avoided during pregnancy because of its teratogenic risk, its impact on fetal survival is poorly understood. This is a case series of lupus patients exposed to cyclophosphamide ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2169oa

    authors: Clowse ME,Magder L,Petri M

    更新日期:2005-01-01 00:00:00

  • Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus.

    abstract::Introduction Osteoprotegerin (OPG) is a member of the tumor necrosis factor (TNF) receptor family. It has recently been demonstrated that OPG is produced by a variety of tissues, including the cardiovascular system (heart, arteries, veins), lung, kidney, immune tissues, and bone. The OPG-RANKL signaling pathway is str...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203316682101

    authors: Kiani AN,Aukrust P,Ueland T,Hollan I,Barr E,Magder LS,Petri M

    更新日期:2017-07-01 00:00:00

  • Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.

    abstract:OBJECTIVE:Arthritis is frequently seen in human lupus, but rarely in lupus models. Pristane-induced lupus (PIL) can be induced in various mouse strains such as BALB/c and C57BL/6. We herein characterize clinical and histological features of arthritis in the context of systemic lupus and provide a prudent comparison wit...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313492869

    authors: Leiss H,Niederreiter B,Bandur T,Schwarzecker B,Blüml S,Steiner G,Ulrich W,Smolen JS,Stummvoll GH

    更新日期:2013-07-01 00:00:00

  • The African Lupus Genetics Network (ALUGEN) registry: standardized, prospective follow-up studies in African patients with systemic lupus erythematosus.

    abstract:BACKGROUND:The prevalence and severity of systemic lupus erythematosus (SLE) differs between ethnic groups and geographical regions. Although initially reported as rare, there is growing evidence that SLE is prevalent and runs a severe course in Africa. There is a paucity of prospective studies on African SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315606984

    authors: Hodkinson B,Mapiye D,Jayne D,Kalla A,Tiffin N,Okpechi I

    更新日期:2016-03-01 00:00:00

  • Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice.

    abstract::Therapeutic agents currently in use to treat systemic lupus erythematosus (SLE) are predominantly immunosuppressive agents with limited specificities. Multiple groups, including ours, have illustrated that inducing tolerance in SLE animal models ameliorates disease symptoms and increases survival. We examined if oral ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311398509

    authors: Skaggs BJ,Lourenço EV,Hahn BH

    更新日期:2011-08-01 00:00:00

  • GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.

    abstract:BACKGROUND:GlycA is a novel marker of systemic inflammation detected by nuclear magnetic resonance (NMR) spectroscopy. In the general population, GlycA is correlated with inflammatory markers such as C-reactive protein (CRP) and associated with coronary heart disease and diabetes. The utility of GlycA in patients with ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617842

    authors: Chung CP,Ormseth MJ,Connelly MA,Oeser A,Solus JF,Otvos JD,Raggi P,Stein CM

    更新日期:2016-03-01 00:00:00

  • Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.

    abstract:OBJECTIVE:The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE). METHODS:We conducted a post-hoc analysis of a long-term followed cohort of Mexican SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600539

    authors: Castillo-Martínez D,Marroquín-Fabián E,Lozada-Navarro AC,Mora-Ramírez M,Juárez M,Sánchez-Muñoz F,Vargas-Barrón J,Sandoval J,Amezcua-Guerra LM

    更新日期:2016-01-01 00:00:00

  • A clinical and serological comparison of familial and non-familial systemic lupus erythematosus in Ireland.

    abstract::Seventeen families, in which the diagnosis of SLE could be verified in two relatives, were included in the study. The diagnosis was made according to the revised 1982 ARA criteria. We compared the 34 cases of familial SLE in these 17 families with 34 non-familial SLE controls matched for age, sex, ethnicity and durati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500408

    authors: Gourley IS,Cunnane G,Bresnihan B,FitzGerald O,Bell AL

    更新日期:1996-08-01 00:00:00

  • The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus.

    abstract::Vitamin D deficiency has been described in systemic lupus erythematosus (SLE). BsmI VDR (vitamin D receptor) gene polymorphism was associated with SLE in Asian patients. Studies in Brazilian populations have not been realized. A case-control study with 195 SLE patients and 201 healthy controls was conducted to investi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311421798

    authors: Monticielo OA,Brenol JC,Chies JA,Longo MG,Rucatti GG,Scalco R,Xavier RM

    更新日期:2012-01-01 00:00:00

  • Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.

    abstract::Immune-mediated sensorineural hearing loss may complicate systemic autoimmune diseases. We have previously reported the presence of antibodies directed against inner ear antigens in patients with Cogan syndrome, a disease characterized by sudden hearing loss and interstitial keratitis. Such autoantibodies cross-react ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316682099

    authors: Bason C,Pagnini I,Brucato A,Maestroni S,Puccetti A,Lunardi C,Cimaz R

    更新日期:2017-07-01 00:00:00